USA flag logo/image

An Official Website of the United States Government

Retina Implantation Instrument Kit

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
70838
Program Year/Program:
2006 / SBIR
Agency Tracking Number:
EY015584
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
OCULAR TRANSPLANTATION, LLC
240 AUDUBON MEDICAL PLAZA LOUISVILLE, KY 40217
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2006
Title: Retina Implantation Instrument Kit
Agency: HHS
Contract: 2R44EY015584-02A1
Award Amount: $684,368.00
 

Abstract:

DESCRIPTION (provided by applicant): The overall goal of this project is to develop a retina implantation instrument kit that will allow: 1) retinal surgeons to harvest, dissect, and transplant sheets of undifferentiated fetal retinal tissue with its retinal pigment epithelium (RPE) and then transplant these cografts into the subretinal space, 2) other transplant protocols for microchips and RPE/choroid patches, and 3) delivery of encapsulated slow-releasing drugs or cell suspensions. The tools in the kit consist of an implantation instrument (a hand piece and nozzles that fit over mandrels), a special microscissors to allow easy harvest and dissection of consistently good preparations of retina/RPE sheets, and a dilator probe to allow easier and more accurate insertion of the implantation instrument into the eye. Results of the Phase I research demonstrate the implantation instrument provides the precise handling and maneuverability required for the transplant procedure and that the nozzles can load and unload tissue without damage to either the cograft sheets or recipient eye. The goal of Phase II is to develop a production-ready retina implantation instrument kit suitable for clinical trials and commercial manufacture and perform testing in preparation for Food and Drug Administration (FDA) approval. A production-ready hand piece will be developed, along with a standardized production process for disposable nozzles and mandrels for cograft implantation. In an extension of the design, prototypes of nozzles/mandrels suitable for other applications will be developed. The other tools in the kit, a furrowed-edge microscissors and a dilator probe, will also be developed. Testing will then be performed in preparation for FDA approval. Following a Phase III effort that includes FDA approval and multi-center clinical trials, a commercial retina implantation instrument kit will be available for transplant applications ranging from fetal cografts to microchips to RPE/choroid patches. Retinal diseases such as macular degeneration, retinal dystrophies, and retinitis pigmentosa (RP) afflict more than 8.5 million Americans. As the population ages, this number will grow significantly, and many people will suffer from vision loss due to degeneration of photoreceptors and/or RPE. With surgeons equipped with the versatile tools in this kit and trained in their use, retinal transplantation will emerge as a near-term, viable technique for the growing number of patients in need of vision preservation and restoration. Retinal diseases such as macular degeneration, retinal dystrophies, and retinitis pigmentosa afflict more than 8.5 million Americans. As the population ages, this number will grow significantly, and many people will suffer from vision loss due to degeneration of photoreceptors and/or retinal pigment epithelium. With surgeons equipped with the versatile tools in this kit and trained in their use, retinal transplantation will emerge as a near- term, viable technique for the growing number of patients in need of vision preservation and restoration.

Principal Investigator:

Robert B. Aramant
5026362823
robert.aramant@louisville.edu

Business Contact:

Norman Radtke
5026362823
ret-vit.resource.ctr@rvrc.com
Small Business Information at Submission:

OCULAR TRANSPLANTATION, LLC
240 AUDUBON MEDICAL PLAZA LOUISVILLE, KY 40217

EIN/Tax ID: 611314305
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No